Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study

被引:5
|
作者
Smith, Adam B. [1 ]
Hanbury, Andria [1 ]
Buesch, Katharina [2 ]
机构
[1] Univ York, York Hlth Econ Consortium Ltd, Enterprise House,Innovat Way, York YO10 5NQ, N Yorkshire, England
[2] PTC Therapeut Inc, 100 Corp Court, South Plainfield, NJ 07080 USA
关键词
AADC deficiency; Vignettes; Time trade-off; Standard gamble; QUALITY-OF-LIFE; TIME TRADE-OFF; STANDARD GAMBLE; RATING-SCALE;
D O I
10.1186/s41687-021-00403-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose The aim of this study was to generate health state utilities for aromatic L-amino acid decarboxylase (AADC) deficiency, a rare genetic, lifelong neurogenerative condition predominantly manifesting in young infants. Methods Participants were presented with health state vignettes. These had been previously developed based on published literature, clinician input, interviews with parents of AADC deficiency patients and expert opinion. A total of 5 health state vignettes were presented: bedridden, head control, sitting unsupported, standing with assistance and walking with assistance. Health state utilities (HSU) were elicited using time-trade off (TTO; 10-year time horizon) and the standard gamble (SG). The vignettes were completed online by panel participants drawn from a representative sample of the United Kingdom residential population. Results A total of 1598 participants completed the vignettes. Around 21% had incongruent responses (higher utilities for the bedridden compared to walking health states). Incongruent responses were associated with shorter task completion times, gender and parental status. These responses were removed from the analysis. Health state utilities (HSU) increased correspondingly as health states improved for both the TTO and SG. The mean HSU (standard deviation) for the TTO task were: bedridden state 0.49 (0.34); head control 0.54 (0.33), sitting unsupported 0.63 (0.31); standing with assistance 0.68 (0.31); and walking with assistance 0.73 (0.31). For the SG, mean health state utilities were: 0.56 (0.28), 0.57 (0.27), 0.67 (0.24), 0.70 (0.24), and 0.75 (0.25), respectively. Conclusion Health state utilities were derived for AADC deficiency through a vignette study. These will be used for a cost-effectiveness model of an AADC deficiency treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus
    Fusco, Carlo
    Leuzzi, Vincenzo
    Striano, Pasquale
    Battini, Roberta
    Burlina, Alberto
    Spagnoli, Carlotta
    ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [22] ECONOMIC BURDEN OF AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY IN EUROPE, FROM THE CAREGIVERS PERSPECTIVE
    Solanke, O.
    Martel, M. J.
    Buesch, K.
    VALUE IN HEALTH, 2022, 25 (01) : S219 - S220
  • [23] The impact of caring for an individual with aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a conceptual model
    Skrobanski, Hanna
    Williams, Kate
    Werner, Christian
    O'Neill, Sian
    Buesch, Katharina
    Acaster, Sarah
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1821 - 1828
  • [24] Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus
    Carlo Fusco
    Vincenzo Leuzzi
    Pasquale Striano
    Roberta Battini
    Alberto Burlina
    Carlotta Spagnoli
    Italian Journal of Pediatrics, 47
  • [25] CARING FOR AN INDIVIDUAL WITH AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY: RESULTS FROM A CAREGIVER QUESTIONNAIRE
    Buesch, K.
    Williams, K.
    Skrobanski, H.
    Acaster, S.
    VALUE IN HEALTH, 2022, 25 (01) : S219 - S219
  • [26] Aromatic L-amino acid decarboxylase deficiency in Taiwan
    Lee, Hsiu-Fen
    Tsai, Chi-Ren
    Chi, Ching-Shiang
    Chang, Tung-Ming
    Lee, Huei-Jane
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (02) : 135 - 140
  • [27] HEALTHCARE RESOURCE CONSUMPTION ASSOCIATED WITH AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC-D) IN ITALY
    Fernandez-Cortes, F.
    Saberian, S.
    Patel, P.
    Rowan, P.
    Buesch, K.
    Beitia Ortiz, De Zarate, I
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S100
  • [28] Estimated prevalence of aromatic l-amino acid decarboxylase (AADC) deficiency in the United States, European Union, and Japan
    Hyland, K.
    Peters, M.
    Schu, M.
    Erickson, S.
    Croxford, J.
    Whitehead, N.
    HUMAN GENE THERAPY, 2018, 29 (12) : A131 - A131
  • [29] HYPOGLYCAEMIA AS A COMPLICATION OF AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
    Eyskens, F. J. M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S130 - S130
  • [30] Eladocagene Exuparvovec for Aromatic L-Amino Acid Decarboxylase Deficiency
    Golikeri, Avanti
    Yi, Sojeong
    Fashoyin-Aje, Lola
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,